ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,270,443 | -21.5% | 1,668,034 | -11.0% | 0.02% | -17.9% |
| Q2 2023 | $57,644,478 | +78369.5% | 1,875,227 | -8.0% | 0.03% | -33.3% |
| Q1 2023 | $73,461 | +88.8% | 2,038,882 | +107.1% | 0.04% | +90.9% |
| Q4 2022 | $38,902 | -98.4% | 984,366 | +1516.8% | 0.02% | +2100.0% |
| Q3 2022 | $2,446,000 | -78.1% | 60,885 | -77.1% | 0.00% | -83.3% |
| Q2 2022 | $11,179,000 | +107.4% | 265,906 | +92.2% | 0.01% | +100.0% |
| Q1 2022 | $5,391,000 | +312.8% | 138,369 | +322.2% | 0.00% | +200.0% |
| Q4 2021 | $1,306,000 | -96.1% | 32,770 | -96.4% | 0.00% | -95.0% |
| Q3 2021 | $33,292,000 | -9.7% | 921,184 | +2.4% | 0.02% | -13.0% |
| Q2 2021 | $36,859,000 | +322.5% | 899,200 | +349.6% | 0.02% | +283.3% |
| Q1 2021 | $8,725,000 | +376.3% | 200,019 | +359.2% | 0.01% | +200.0% |
| Q3 2020 | $1,832,000 | -94.8% | 43,557 | -94.0% | 0.00% | -95.8% |
| Q2 2020 | $35,043,000 | – | 721,802 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |